Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”Unfractionated heparin has been used for decades.
But using it well still requires careful clinical decisions.
When is UFH preferable to other anticoagulants?
Should treatment begin with a bolus?
When might a no – bolus strategy make more sense?
And how can the risks associated with UFH infusions be reduced?
At Thrombosis Unpacked: Decisions That Matter, Dr. Matthew Nicholson will take a modern look at this familiar anticoagulant in Unfractionated Heparin: Old Drug, Narrow Lane, focusing on where UFH still belongs in clinical practice and strategies to improve its safe use.
Join colleagues from across Canada to explore practical approaches to difficult thrombosis and anticoagulation decisions.
November 7, 2026 | Montréal.‘
Other posts featuring Thrombosis Canada on Hemostasis Today.
-
Sep 8, 2026, 12:24Alejandro González Veliz: Can a Stent Cause a Heart Attack?
-
Sep 8, 2026, 11:15Andreas Tridimas: Atherosclerosis Is Greyer Than We Admit
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear